Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target

UDC.coleccionInvestigaciónes_ES
UDC.departamentoFisioterapia, Medicina e Ciencias Biomédicases_ES
UDC.endPage987es_ES
UDC.grupoInvEnfermidades Cerebrovasculares: Neuroloxía Clínica e Traslacional (INIBIC)es_ES
UDC.institutoCentroINIBIC - Instituto de Investigacións Biomédicas de A Coruñaes_ES
UDC.issue4es_ES
UDC.journalTitleStrokees_ES
UDC.startPage982es_ES
UDC.volume33es_ES
dc.contributor.authorCastellanos, María del Mar
dc.contributor.authorCastillo, José
dc.contributor.authorGarcía, María M.
dc.contributor.authorLeira, Rogelio
dc.contributor.authorSerena, Joaquín
dc.contributor.authorChamorro, Ángel
dc.contributor.authorDávalos, Antoni
dc.date.accessioned2025-01-09T12:20:53Z
dc.date.available2025-01-09T12:20:53Z
dc.date.issued2002-04-01
dc.description.abstract[Abstract] Background and purpose: The mechanisms underlying neurological deterioration in patients with lacunar infarction are not completely understood. In this study, we sought to investigate the role of proinflammatory molecules in the early worsening and outcome of acute lacunar stroke. Methods: We performed a secondary analysis of 113 consecutive patients with lacunar infarction included within the first 24 hours of the onset of symptoms in a previous study aimed at investigating clinical and biochemical factors of early neurological deterioration (END). END was defined as a fall of > or =1 points in the motor items of Canadian Stroke Scale between inclusion and 48 hours. Poor outcome at 3 months was considered death or Barthel Index <85. Interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and intercellular adhesion molecule-1 (ICAM-1) were determined by enzyme-linked immunoabsorbent assay in blood samples obtained on admission. Results: END was recorded in 27 patients (23.9%); poor outcome was noted in 26 (23%). Median (quartiles) concentrations in plasma of TNF-alpha [16.5 pg/mL (13.7 and 21.2 pg/mL) versus 7.5 pg/mL (6.2 and 9.0 pg/mL)], IL-6 [28.8 pg/mL (22.5 and 35.7 pg/mL) versus 11.5 pg/mL (8.5 and 16.2 pg/mL)], and ICAM-1 [285 pg/mL (219 and 315 pg/mL) versus 158 pg/mL (137 and 187 pg/mL)] were significantly higher in patients who had END than in those with nonprogressing strokes (P< 0.001). Significant differences were also observed between patients with poor and good outcome at 3 months. Logistic regression analysis after adjustment for potential confounders showed that TNF-alpha >14 pg/mL and ICAM-1 >208 pg/mL were independently associated with both END (OR, 511; 95% CI, 17 to 4937; P<0.001; and OR, 315; 95% CI, 17 to 5748; P< 0.001, respectively) and poor outcome at 3 months (OR, 3.0; 95% CI, 1.0 to 8.5; P=0.042; and OR, 4.2; 95% CI, 1.3 to 13.6; P<0.015, respectively). Conclusions: High concentrations of inflammatory markers in blood are associated with END and poor functional outcome in lacunar infarctions. These findings suggest that inflammation contributes to brain injury in lacunar stroke.es_ES
dc.description.sponsorshipXunta de Galicia; PGIDT99PX120803Bes_ES
dc.identifier.citationCastellanos M, Castillo J, García MM, Leira R, Serena J, Chamorro A, Dávalos A. Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target. Stroke. 2002 Apr;33(4):982-7.es_ES
dc.identifier.doi10.1161/hs0402.105339
dc.identifier.issn0039-2499
dc.identifier.urihttp://hdl.handle.net/2183/40638
dc.language.isoenges_ES
dc.publisherAmerican Heart Associationes_ES
dc.relation.urihttps://doi.org/10.1161/hs0402.105339es_ES
dc.rights.accessRightsopen accesses_ES
dc.subjectCytokineses_ES
dc.subjectInflammationes_ES
dc.subjectLacunar infarctiones_ES
dc.subjectStroke outcomees_ES
dc.titleInflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic targetes_ES
dc.typejournal articlees_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationfea87394-0be5-482f-b650-543f2240258c
relation.isAuthorOfPublication.latestForDiscoveryfea87394-0be5-482f-b650-543f2240258c

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Castellanos_Inflammation_2002.pdf
Size:
726.93 KB
Format:
Adobe Portable Document Format
Description: